MBMD 2 vs ChemoSavvy
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MBMD 2
This mobile application connects with a hospital communications web application. It facilitates communication and information exchange within a healthcare setting.
- Hospital communications integration
- Web application companion
- Mobile access to hospital systems
Read full descriptionHide full description
The MBMD mobile app is designed for use the with the MBMD hospital communications web application.
ChemoSavvy
This app helps users track their capecitabine treatment cycle. It automatically records dose times, allows for daily notes, and exports all information when the cycle ends. Users can also manually adjust times and pause or restart their cycle as needed.
- Track capecitabine treatment cycles
- Automatic dose time input
- Add daily notes
- Export all cycle notes
- Manually adjust dose times
- Pause and restart cycle
Read full descriptionHide full description
Track your capecitabine cycle with this simple easy to use app. App automatically inputs the time when you click that you have taken a dose. Notes can be easily added for each day and when you end your cycle all notes are automatically saved and exported for you. You can manually adjust times if you made a mistake and you can quickly pause and restart your cycle.
Screenshots
Verdict
The clearest difference is rating: ChemoSavvy at 5.0 against MBMD 2's 3.0. ChemoSavvy also leads on update cadence (monthly vs every 4 months). MBMD 2's advantage is ratings volume (4 vs 1) and iOS requirement (15.1 vs 26.2). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
ChemoSavvy holds the better App Store score, 5.0 against 3.0. Both are backed by a comparable volume of ratings — 4 and 1 respectively.
MBMD 2 ships an update every 4 months, ChemoSavvy monthly. The most recent releases landed on November 3, 2026 and October 31, 2026 respectively.
| Parameter | MBMD 2 | ChemoSavvy |
|---|---|---|
| Price | Free | Free |
| Rating | 3.0 (4 ratings) | 5.0 (1 ratings) — better |
| Positive reviews | 0.0% of reviews | — |
| Number of ratings | 4 — better | 1 |
| Update frequency | Every 4 months | Monthly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 15.1 — better | 26.2 |
| Further details — not scored | ||
| Size | 57 MB | 1 MB |
| Age rating | 4+ | 4+ |
| Developer | M2 Information Systems Inc. | Semi Modular LLC |
Customer experience
MBMD 2
ChemoSavvy
In-app purchases
MBMD 2
No in-app purchases
ChemoSavvy
No in-app purchases
